£1.8M
Mercia Ventures led the seed financing round with participation from several backers to support platform validation and team growth.
"Enzymes play a wide-ranging role in disease, but current technologies are unable to develop drugs to tackle most of them. Our team at Kuano recognised the need to overcome these limitations."
Mercia Ventures + 4 others
